A-Alpha Bio

A-Alpha Bio was founded in 2017 and is headquartered in Seattle, United States. The company works in AI protein and enzyme design within synthetic biology. Its AlphaSeq platform uses yeast mating to measure protein-protein binding affinities at scale, generating the interaction data used to characterize antibodies, engineered proteins, and molecular glues. AlphaBind is a domain-specific deep-learning model trained on that data to predict binding strength and support design of antibodies and other therapeutic proteins; biopharma partners use it to prioritize candidates before lab work. Atlas is a web-based data ecosystem offering licensable Data Blocks, Custom Data Blocks, and an Atlas Consortium that pools standardized antibody-antigen measurements across member companies. The company's stated revenue model centers on platform use, data licensing, and custom data commissions, though its specific commercial terms are not provided in the source data. Total capital raised and funding rounds are not disclosed in the available data. The company is privately held and reports a headcount in the 11-50 range.